OR WAIT null SECS
© 2022 MJH Life Sciences and Psychiatric Times. All rights reserved.
© 2022 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
June 22, 2022
Over the past 6 months, Psychiatric Times has featured expert opinions on important psychiatric issues from psychosis to psychedelics.
June 20, 2022
Does the “early bird get the worm”? Researchers investigated long-term outcomes with an early-switch long-acting injectable antipsychotic in patients with schizophrenia using a population-based cohort.
June 17, 2022
Interim study results show 77% treatment response rate among participants.
June 16, 2022
Postpartum psychosis is experienced by 1 to 2 women every 1000 deliveries.
June 15, 2022
Sociocultural factors have been shown to impact both the presentation and course of schizophrenia/psychosis. Learn more here.
June 14, 2022
Researchers investigated population-level phenotypes occurring before and after diagnosis of schizophrenia using a large health insurance claims dataset.
In this Special Report, clearly delineate the clinical context of selective psychoses.
June 06, 2022
What are the benefits of early and comprehensive intervention for patients in their first episode of a serious mental illness?
June 02, 2022
"This pandemic represents an unprecedented time that requires a psychiatrist’s vigilance in identifying patients at risk for COVID-19–induced psychosis."
May 09, 2022
“In the general population, insomnia is associated with greater cognitive impairment, but its association (and potential sexual dimorphic effect) in schizophrenia is less clear.”